CPIA
IBB icon

Cornell Pochily Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Cornell Pochily Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
+1,140
New +$196K 0.06% 186
2022
Q1 		– Sell
-1,409
Closed -$215K – 172
2021
Q4 		$215K Buy
1,409
+1
+0.1% +$155 0.08% 156
2021
Q3 		$228K Buy
1,408
+130
+10% +$21.9K 0.1% 153
2021
Q2 		$209K Sell
1,278
-95
-7% -$14.6K 0.09% 155
2021
Q1 		$207K Hold
1,373
– – 0.1% 144
2020
Q4 		$208K Buy
+1,373
New +$196K 0.1% 144

Other funds holding IBB

GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SCA
Southern Capital Advisors Jackson, Tennessee $239M AUM 22.42% 1-Year Est. Return

Cornell Pochily Investment Advisors's IBB Position: Q2 2026 in Review

Cornell Pochily Investment Advisors opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,140 shares worth $217K. The stake represents 0.06% of the portfolio and ranks #186 among its holdings. This is a return to the name: Cornell Pochily Investment Advisors previously reported a position in IBB as recently as Q4 2021.

Cornell Pochily Investment Advisors first reported a position in IBB in Q4 2020 and has held it in 6 quarters since. The position peaked at $228K in Q3 2021. 158 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Cornell Pochily Investment Advisors held 1,140 shares of iShares Biotechnology ETF worth $217K as of Q2 2026.
  • iShares Biotechnology ETF was a new Cornell Pochily Investment Advisors position in Q2 2026.
  • iShares Biotechnology ETF made up 0.06% of Cornell Pochily Investment Advisors's portfolio in Q2 2026, its #186 holding.
  • Cornell Pochily Investment Advisors first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 6 quarters since.
  • Cornell Pochily Investment Advisors's iShares Biotechnology ETF position peaked at $228K in Q3 2021.
  • 158 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Cornell Pochily Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.